Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets

被引：0
|
作者：
Gasparyan, Armen Yuri [1 ]
机构：
[1] Russells Hall Hosp, Dudley Grp NHS Fdn Trust, Dudley DY1 2HQ, W Midlands, England
来源：
CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 11期
关键词：
RHEUMATOID-ARTHRITIS; ACCELERATED ATHEROSCLEROSIS; ALPHA THERAPY; DISEASE; ANEURYSMS; STATINS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1447 / 1449
页数：3
相关论文
共 50 条
  • [1] Elucidation of the pathophysiological mechanisms and drug targets for leptin resistance in the CNS
    Hosoi, Toru
    Ozawa, Koichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S69 - S69
  • [2] Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease
    Dubois, Vanessa
    Lefebvre, Philippe
    Staels, Bart
    Eeckhoute, Jerome
    GUT, 2024, 73 (09) : 1562 - 1569
  • [3] Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk
    Volgman, Annabelle Santos
    Koschinsky, Marlys L.
    Mehta, Anurag
    Rosenson, Robert S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (12):
  • [4] Pathophysiological Aspects of Inflammation and Drug Design: an Updated Overview
    Etienne, Rachelle
    Dias Viegas, Flavia Pereira
    Viegas Jr, Claudio
    REVISTA VIRTUAL DE QUIMICA, 2021, 13 (01) : 167 - 191
  • [5] Autoimmunity and Autoinflammation: Cardiovascular Drug Targets and Design
    Gasparyan, Armen Yuri
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (04) : 483 - 485
  • [6] BACTERIAL OSMOADAPTATION MECHANISMS AS TARGETS FOR DRUG DESIGN
    ABDELGHANY, YS
    MILLER, DD
    KUNIN, CM
    TONG, HH
    INHAT, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 61 - MEDI
  • [7] FLAVONOIDS AND CARDIOVASCULAR RISK FACTORS: FOCUSING ON POSSIBLE PATHOPHYSIOLOGICAL MECHANISMS OF ACTION
    Grassi, D.
    Ferri, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [8] Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets
    Ahmad, Muzamil
    Dar, Nawab J.
    Bhat, Zubair S.
    Hussain, Aehtesham
    Shah, Ayatullah
    Liu, Hao
    Graham, Steven H.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (08) : 1378 - 1396
  • [9] Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
    Miller, Ashley M.
    McInnes, Iain B.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (01) : 1 - 8
  • [10] Neurogenic inflammation: Mechanisms and pathophysiological implications.
    Geppetti, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (02) : 342 - 342
12345